MENU
+Compare
RNXT
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$1.50
Change
+$0.09 (+6.38%)
Capitalization
36M

RNXT RenovoRx Forecast, Technical & Fundamental Analysis

Industry Biotechnology
RNXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for RNXT with price predictions
Jan 08, 2025

Momentum Indicator for RNXT turns positive, indicating new upward trend

RNXT saw its Momentum Indicator move above the 0 level on December 30, 2024. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 64 similar instances where the indicator turned positive. In of the 64 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for RNXT just turned positive on January 02, 2025. Looking at past instances where RNXT's MACD turned positive, the stock continued to rise in of 34 cases over the following month. The odds of a continued upward trend are .

RNXT moved above its 50-day moving average on December 19, 2024 date and that indicates a change from a downward trend to an upward trend.

The 50-day moving average for RNXT moved above the 200-day moving average on December 31, 2024. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RNXT advanced for three days, in of 145 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 25 cases where RNXT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RNXT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RNXT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.092) is normal, around the industry mean (14.746). P/E Ratio (0.000) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). RNXT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (264.084).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RNXT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
RNXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RNXT is expected to report earnings to -10 cents per share on February 27

RenovoRx RNXT Stock Earnings Reports
Q4'24
Est.
$-0.10
Q3'24
Beat
by $0.02
Q2'24
Est.
$-0.10
Q1'24
Est.
$-0.07
Q4'23
Est.
$-0.31
The last earnings report on November 14 showed earnings per share of -10 cents, beating the estimate of -11 cents. With 353.00K shares outstanding, the current market capitalization sits at 36.00M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
4546 El Camino Real
Phone
+1 650 284-4433
Employees
8
Web
https://www.renovorx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPIR17.981.34
+8.05%
Spire Global
CODX0.800.02
+2.53%
Co-Diagnostics
EXPO92.34-0.41
-0.44%
Exponent
ARGX640.52-19.29
-2.92%
argenx SE
LESL2.16-0.07
-3.14%
Leslie's

RNXT and Stocks

Correlation & Price change

A.I.dvisor tells us that RNXT and SPRB have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RNXT and SPRB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNXT
1D Price
Change %
RNXT100%
+6.38%
SPRB - RNXT
28%
Poorly correlated
-4.75%
VTVT - RNXT
24%
Poorly correlated
+0.04%
SLNCF - RNXT
24%
Poorly correlated
-8.26%
LPTX - RNXT
24%
Poorly correlated
-1.16%
PRLD - RNXT
24%
Poorly correlated
+2.94%
More